HIPAA-Compliant Data Governance and Brand Partitioning for Cell Therapy Manufacturers
Scaling clinical trials demands strict HIPAA compliance across marketing and operational workflows. For a cell therapy manufacturer, we used HubSpot Enterprise's sensitive data features and brand partitioning. The result is a secure, bi-directional architecture. It segments Protected Health Information (PHI) by function while keeping one unified record for clinical visibility.
Executive Summary
Context
A Pittsburgh-based biotech manufacturing leader specializing in autologous muscle-derived cells and GMP-grade research services.
What We Built
A governance-first HubSpot Enterprise architecture. Brand partitioning and sensitive data tools keep HIPAA compliance in place across global operations.
Tech Stack
- HubSpot Enterprise (Marketing, Sales, Service, Content Hubs) and native HubSpot Sensitive Data features.
Not a fit for organizations without defined regulatory compliance requirements. If you operate in a non-sensitive commercial environment, data partitioning just adds overhead you don't need.
The Challenge
Personalized cell therapies like Iltamiocel carry data risks a standard CRM environment can't manage at clinical-trial scale. The client needed centralized lead management for research contract services, and they needed sensitive data strictly isolated to keep HIPAA compliance intact. Both at once. Without precise partitioning, protected data could leak between administrative, marketing, and laboratory service teams, putting clinical integrity and regulatory standing at risk.
Our Approach
Work began in July 2024 with the data partitioning logic needed for safe scaling. HubSpot's sensitive data features encrypt and protect personal health information at rest. We implemented brand partitioning to put logical barriers between the different operational arms, so research service leads and clinical subject data stay visible only to authorized personnel. Custom form routing rounds it out. Inquiries from the "Contact Us" and newsletter modules go straight to specific, HIPAA-trained staff, so response is immediate and the data never gets broad distribution.
Impact
Regulatory Compliance Baseline
Sensitive data features created a verified HIPAA-compliant environment. The organization can now store and process investigational cell therapy lead data safely.
Operational Security via Partitioning
Brand partitioning cut internal data risk. Record access is strictly limited to the appropriate functional teams: Marketing, Sales, and Service.
Targeted Response Logic
Custom form routing delivers high-stakes inquiries, such as phase-appropriate GMP manufacturing requests, only through authorized notifications. Data privacy holds. Lead response speed improved.
Cross-Hub Governance
Unified governance protocols span Marketing, Sales, and Service Hubs. Every sensitive data interaction leaves a consistent audit trail, which supports the client's ISO-certified quality standards.
HubSpot's Enterprise-tier Sensitive Data tools define and encrypt the specific properties that hold protected information. Those fields are excluded from non-essential reporting and third-party tracking.
Team-based permissions and brand partitioning settings isolate records and content assets. Data can't leak across departments, from research contract services into clinical trial management.
We engineered custom routing for inbound lead forms. Submissions bypass standard broad distribution and go to direct, authorized notifications, which preserves the chain of custody for sensitive inquiries.
A standardized permission matrix covers Marketing, Sales, and Service Hubs. User access levels apply consistently everywhere. Collaborative tasks that cross functions can't accidentally expose data.
A data governance architecture leveraging HubSpot Enterprise’s sensitive data features and brand partitioning. It creates a secure, bi-directional environment for cell therapy manufacturers to segment Protected Health Information (PHI) while maintaining unified clinical visibility.
FAQ
Encrypted fields designated as "sensitive data" are blocked from general reporting exports and from specific non-compliant dashboards. Operational teams can still act on individual records. Aggregate marketing reports, though, can't accidentally leak protected health information into non-secure documents.
Yes. The architecture is modular. New clinical trial indications or laboratory services can be added as distinct partitioned segments inside the existing HubSpot Enterprise instance. Compliance standards stay the same, and no total system redesign is required.
